Does RUXOLITINIB Cause Dysphonia? 196 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Dysphonia have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.3% of all adverse event reports for RUXOLITINIB.
196
Reports of Dysphonia with RUXOLITINIB
0.3%
of all RUXOLITINIB reports
8
Deaths
43
Hospitalizations
How Dangerous Is Dysphonia From RUXOLITINIB?
Of the 196 reports, 8 (4.1%) resulted in death, 43 (21.9%) required hospitalization.
Is Dysphonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 196 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Dysphonia?
FLUTICASONE\SALMETEROL (1,729)
CABOZANTINIB S-MALATE (1,229)
ADALIMUMAB (1,216)
BUDESONIDE\FORMOTEROL (1,204)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143)
ALBUTEROL (1,114)
LENVATINIB (1,021)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943)
LENALIDOMIDE (931)
AMIKACIN (914)
Which RUXOLITINIB Alternatives Have Lower Dysphonia Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE